Clinical Trial Update: Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance

View source ↗

Summary

This clinical trial update examines adherence to lenalidomide therapy in multiple myeloma, including prevalence, characteristics of non-adherence, and its poten…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Rabin Medical Center | Conditions: Patient Non-adherence | Status: UNKNOWN